Medication info
Simvastatin/Ezetimibe Tablet 10/20

Simvastatin/Ezetimibe Tablet 10/20

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Hana Pharm Co., Ltd.
Appearance
White to off-white, double convex, rectangular tablet
Packaging
30 tablets (10 tablets x 3 PTP packages)
Approval status
Active

MFDS item code 201600960 · Approved 2016.02.19 · Insurance code 649102990

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg per day. The usual recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Hana Pharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease caused by hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication is used to lower elevated total cholesterol and bad cholesterol (LDL-C), apolipoprotein B, and triglycerides while increasing good cholesterol (HDL-C) in patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also administered as an adjunct in patients with homozygous familial hypercholesterolemia or when other treatments are ineffective. This medication is intended to be used alongside dietary therapy and is applied when there is insufficient response to non-drug treatments, such as limiting saturated fats and cholesterol. It is important to identify and treat secondary causes such as diabetes and hypothyroidism before treatment. Lipid tests should be performed regularly throughout the treatment process, including total cholesterol, LDL, HDL, and triglycerides, to ensure proper control. This medication is effectively used to reduce the risk of hypercholesterolemia and related vascular diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg per day. The usual recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is predominantly used for treating hypercholesterolemia and helps improve heart and vascular health. When taking this medication, caution is required as serious muscle-related side effects, such as myopathy and rhabdomyolysis, may occur. These side effects may include muscle pain, muscle weakness, and in severe cases, lead to kidney damage. The risk of muscle side effects may increase, especially when taken in high doses or alongside specific medications, so it is essential to inform your doctor or pharmacist if you are taking any other medications. It is safer not to use this medication in patients with compromised liver function or liver disease. Additionally, women who are pregnant or breastfeeding should not take this medication, and women planning to become pregnant should consult with their doctor before use. Taking this medication alongside drugs that inhibit certain enzymes may increase blood concentration and the risk of side effects; therefore, dosage adjustment or discontinuation of this medication may be necessary if you are taking such medications. If unexplained muscle pain or weakness occurs during treatment, notify your doctor immediately, and regular blood tests to check muscle enzyme levels are recommended. This medication should be used more cautiously in elderly patients or those with reduced kidney function, and regular monitoring of liver function and blood glucose levels is advisable. It is recommended to avoid alcohol consumption while taking this medication, and caution is advised with specific foods like grapefruit juice that may affect the medication's effectiveness. For safety and efficacy, this medication should be taken strictly according to the physician's instructions regarding the correct method and dosage, and you should not discontinue or change the dosage on your own.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 76 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • itching
  • rash
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • alopecia
  • various skin changes
  • drug eruption resembling lichen planus
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated aminotransferase
  • elevated ALP
  • elevated γ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss
  • edema
  • thirst
  • facial edema
  • syncope
  • psychiatric disorders
  • anxiety
  • sleep disturbances
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • psychiatric disorders
  • memory impairment
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to off-white, double convex, rectangular tablet

Package unit

30 tablets (10 tablets x 3 PTP packages)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.